Form4insider filings, from the source

SEC Form 4 · accession 0001838139-26-000024

Royalty Pharma plc · RPRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Marshall Urist
Officer — EVP, Research & Investments
Period of report
Aug 5, 2026
Accepted (ET)
Aug 7, 2026 · 5:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001802768

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Ordinary SharesF1Aug 5, 2026A8,252$0.00A8,252D
Class A Ordinary Sharesholding———19,020IBy IRA

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
LP interests in RPI US Partners 2019, LPF2,F3—Aug 7, 2026G3,000D——Class A Ordinary Shares30,000244,412I

Explanation of responses

Remarks

In addition to the Class A Ordinary Shares disclosed above, the Reporting Person holds Class E Ordinary Shares of Holdings exchangeable into 1,356,528 Class A Ordinary Shares. Class E Ordinary Shares of Holdings are subject to vesting conditions.